Grünenthal successfully extends its term loan bank facilities
12.2.2021 13:46:41 CET | news aktuell GmbH | Pressemelding
Aachen, Germany, 12 February 2021 – Grünenthal has announced the successful extension of its existing €535 million term loan bank facilities. This amendment was conducted in the broader context of the company’s acquisition of the European rights (excluding Spain and the UK) to the lipid-lowering medication CRESTOR™ completed in February 2021. The term loan maturities are now aligned with Grünenthal’s Revolving Credit Facility maturity, which further extends its debt maturity profile. More than 60 percent of Grünenthal’s debt facilities now mature in 2024 or later.
“By extending the maturity of our financing, we have gained additional flexibility to further fund our growth strategy,” says Fabian Raschke, Chief Financial Officer of Grünenthal. „We will continue to explore opportunities to further support our organic growth with targeted acquisitions, that fit our EBITDA and cash flows accretive acquisition strategy.“
Grünenthal’s capital structure has enabled it to enter into a series of acquisitions and partnerships in recent years. The company has signed transactions with a total value of more than US$ 1.7 billion since 2016. These include the global rights to Qutenza™ and the global (excluding Japan) rights to Zomig™, as well as the European rights to Nexium™ and global (excluding US and Japan) rights to Vimovo™, which is the biggest single investment in the company’s history.
“These transactions are vital building blocks to support Grünenthal’s strategy of generating deals that strengthen our financial performance and enable us to reinvest in pain research,” explains Fabian Raschke.
About Grünenthal
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.
Grünenthal is headquartered in Aachen, Germany, and has affiliates in 29 countries across Europe, Latin America and the US. Our products are available in more than 100 countries. In 2019, Grünenthal employed around 4,700 people and achieved sales of € 1.4 bn.
More information: www.grunenthal.com
Follow us on:
LinkedIn: Grunenthal Group
Instagram: grunenthal
Kontakter
For further information, please contact:
Fabia Kehren, Head External Communications & Editorial Management
Tel.: +49 241 569-3269
Fabia.Kehren@grunenthal.com
Grünenthal GmbH, 52099 Aachen, Germany
Lenker
Om news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
PARACELSUS MEDICAL UNIVERSITY: PHARMACY PROGRAM GOES INTERNATIONAL16.11.2026 09:00:00 CET | Press release
Starting in the fall of 2027, the “Pharmacy and Pharmaceutical Sciences” program will be the first English-taught pharmacy program in the German-speaking region to qualify students to work across a range of pharmacy roles and settings.
Infomaniak and Gruyère Energie develop a data center project in Bulle designed to limit its footprint13.11.2026 13:41:04 CET | Press release
Geneva and Bulle, 13 November 2026 – Infomaniak SA (SIX: INFO), a Swiss cloud provider, and Gruyère Energie SA announce that the planning application for a data center in Bulle will be put on public display on 13 November. Planned for 2028, this next-generation facility is intended to meet growing digital needs while reusing the heat produced by its servers in the existing district heating network. Its planned IT capacity of 2.5 megawatts (MW) is twice that of Infomaniak’s most recent data center, in Geneva. The project remains modest in size.
HEIDELBERG sees sequential improvement in business performance in a challenging geopolitical environment12.11.2026 09:07:04 CET | Press release
• Incoming orders high in second quarter of financial year 2026/2027 and around 3 percent higher after six months compared with equivalent period of previous year • Sequential increase in sales and EBITDA margin during financial year • Focus on strategic priorities – integration of manroland sheetfed proceeding according to plan • Geopolitical crises and advance outlay hit profitability • Forecast for financial year 2026/2027 – stable sales and adjusted EBITDA margin of between 5.6 and 6.6 percent
Polarise plans to add roughly 150 megawatts of new AI capacity in Germany by the end of 2028 - Named “Hidden Champion” by the German AI Association12.11.2026 08:49:30 CET | Press release
Upcoming AI Factories will be established in Bavaria, Hesse, and North Rhine-Westphalia - the award recognizes the development of sovereign AI infrastructure
Leading Spa Award 2026: 64 Wellness Hotels Across Six European Countries Honoured10.11.2026 10:30:00 CET | Press release
Europe’s outstanding wellness destinations recognised for exceptional spa experiences and hospitality.
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.
Besøk vårt presserom

